{
    "2021-03-05": [
        [
            {
                "time": "2021-03-05",
                "original_text": "通化东宝：牵手药明康德 强势进军创新药领域",
                "features": {
                    "keywords": [
                        "通化东宝",
                        "药明康德",
                        "创新药",
                        "战略合作"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-05",
                "original_text": "药明康德(02359-HK)去年盈利增59.62%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "盈利增长",
                        "59.62%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-05",
                "original_text": "药明康德业绩快报：2020年度净利润29.6亿元 同比增长59.62%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "业绩快报",
                        "净利润",
                        "29.6亿元",
                        "同比增长",
                        "59.62%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-05",
                "original_text": "通化东宝(600867.SH)与上海药明康德就糖尿病等疾病治疗领域达成战略合作",
                "features": {
                    "keywords": [
                        "通化东宝",
                        "药明康德",
                        "糖尿病",
                        "战略合作"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-05",
                "original_text": "北向资金今日小幅净买入5.27亿元，贵州茅台连续7日净卖出",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "贵州茅台",
                        "净卖出"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "食品饮料"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-05",
                "original_text": "医药生物行业：第四批集采落地 建议上游原料药行业",
                "features": {
                    "keywords": [
                        "医药生物",
                        "第四批集采",
                        "原料药"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-05",
                "original_text": "【异动股】药明康德(02359-HK)跌4.52%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "异动股",
                        "下跌",
                        "4.52%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}